Author

Su Yeong Park

Institutions: Hanmi Pharmaceutical (South Korea), Soonchunhyang University Hospital Bucheon

Observed institutions: Inha University, Hanmi Pharmaceutical (South Korea), Chosun University Hospital, Inha University Hospital, Soonchunhyang University Hospital Bucheon

ORCID: 0000-0001-7108-4350

Observed ORCID: 0000-0001-7108-4350

OpenAlex ID: A5088897946

Antinociceptive effects of intrathecal cimifugin treatment: a preliminary rat study based on formalin test

2020 · Hyun Young Lee, Young Joon Ki, et al. · Anesthesia and Pain Medicine · 9

Dexmedetomidine as a non-triggering anesthetic agent in a patient with MELAS syndrome and systemic sepsis - A case report -

2019 · Sang Hun Kim, Su Yeong Park, et al. · Anesthesia and Pain Medicine · 7

Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction

2023 · Su Yeong Park, Min Gyu Kong, et al. · The Korean Journal of Internal Medicine · 3

Incidence of atrial fibrillation in patients with renal infarction: A retrospective cohort analysis of the Korean national health insurance registry

2024 · Inki Moon, Su Yeong Park, et al. · International Journal of Cardiology

Hemo-metabolic impairment in patients with ST-segment elevation myocardial infarction: Data from the INTERSTELLAR registry

2023 · Min Gyu Kong, Jon Suh, et al. · Cardiology Journal

Abstract P3168: Identification Of Exosome MicroRNA In Association With Severe Calcification In Coronary Chronic Total Occlusion

2023 · Ji-Hye Son, Hun Soo Chang, et al. · Circulation Research

Works count: 6

Citation count: 19

H-index: 3

I10-index: